Biomedical experiments and public safety
Two leading scientific journals have been asked not to publish details of research into the deadly bird flu virus. The research involved creating a highly transmissible version of H5N1. The scientists hope to gain valuable data that could lead to a vaccine. But the National Science Advisory Board for Biosecurity said the experiments, if made public, could be used by bioterrorists. Their decision raises many questions – including should the scientists have created the deadly new variation in the first place. Join us to discuss whether publishing research into virulent diseases is a threat or a benefit to public health.
director of the National Institute of Allergy and Infectious Diseases/NIH.
Director, Johns Hopkins Berman Institute of Bioethics;
Director of the Center for Infectious Disease Research and Policy and Director of the NIH-sponsored Minnesota Center of Excellence for Influenza Research and Surveillance
Board member, National Science Advisory Board on Biosecurity